Ledger.Open graph →
SEC Form D · filed January 12, 2018

ENDOSTIM, INC

Offering
$25.0M
Sold
$12.1M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
Dallas, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Virender K. Sharma · Dallas, TXExecKimberly S. Pinson · Dallas, TXExecRohan J. Hoare · Dallas, TXExec · DirectorPaul K. Goode · Dallas, TXExecAlexander S. Schmitz · Dallas, TXDirectorDouglas D. French · St. Louis, MODirectorAlex Diaz-Asper · Palm Beach, FLExecJon Pelzer · Palm Beach, FLExecDonald A. Direnzo, Jr · Jericho, NYExec · DirectorFrederic Meriot · NEW YORK, NYDirectorJanet Gervasio · NEW YORK, NYExecJohn Miskel · New York, NYDirectorMichael F. Noel · Research Triangle Park, NCDirectorMary Ann W. Todd · Chicago, ILExec · DirectorMark Srulowitz · New York, NYExecJaspreet Dehl · New York, NYDirectorKeiji Hattori · New York, NYExecRon Bloom · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗